Neurology Center of New England

Foxborough, Massachusetts 02035

3 studies enrolling now · 11 studies all time

What they study most

Alzheimer Disease, Amyloid, Cognitive Dysfunction, Generalized Myasthenia Gravis, Lewy Body Disease, Migraine, Multiple Sclerosis Spasticity, Multiple Sclerosis, Relapsing-Remitting, Parkinson Disease, Parkinson Disease Psychosis, Relapsing-Remitting Multiple Sclerosis, Synucleinopathies

Studies at this site

• A Study of Donanemab (LY3002813) in Participants With Early Cognitive Decline (TRAILBLAZER-ALZ 7) — Recruiting now
• A Study of Telitacicept for the Treatment of Generalized Myasthenia Gravis (UPSTREAM MG) — Recruiting now
• A Study to Evaluate the Efficacy, Safety and Tolerability of BMS-986368 in Participants With Multiple Sclerosis Spasticity — Recruiting now
• Simufilam 50 mg or 100 mg for Mild-to-Moderate Alzheimer's Disease — Stopped early
• Open-label Extension for Phase 3 Clinical Trials of Simufilam — Stopped early
• Study to Evaluate the Effectiveness and Safety of Ocrelizumab in Participants With Early Stage Relapsing Remitting Multiple Sclerosis (RRMS) — Stopped early
• A Study to Evaluate Treatment Satisfaction With Erenumab in Participants With Migraine — Completed
• Utilization of Target Ranges to Treat Parkinson's Disease With the PKG — Stopped early
• The INSYTE (Management of Parkinson's Disease Psychosis in Actual Practice) Study — Stopped early
• Observational Registry of Acthar Gel for Participants With Multiple Sclerosis Relapse — Completed
• Retrospective Study to Determine Effect of Rebif and Tecfidera on Infections and Lymphocytes — Completed